Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Varenicline For Nicotine Vaping Cessation In Non Smoker Vaper Adolescents

NCT04602494 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04602494
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04602494 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Varenicline For Nicotine Vaping Cessation In Non Smoker Vaper Adolescents
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Terminated
Start date
December 18, 2020
Completion date
June 27, 2022
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nicotine dependence, vaping